4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors
摘要:
Novel 4-phenyl tetrahydroisoquinolines that inhibit both dopamine and norepinephrine transporters were designed and prepared. In this Letter, we describe the synthesis, in vitro activity and associated structure-activity relationships of this series. We also report the ex vivo NET occupancy of a representative compound, 41. (C) 2012 Elsevier Ltd. All rights reserved.
4-PHENYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE AND SEROTONIN
申请人:ALBANY MOLECULAR RESEARCH, INC.
公开号:EP1246805A1
公开(公告)日:2002-10-09
4-PHENYL SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE AND SEROTONIN
申请人:AMR Technology, Inc.
公开号:EP1827435A2
公开(公告)日:2007-09-05
Use of 4-phenyl-substituted tetrahydroisoquinolines in the treatment of pain, migraine headaches and urinary incontinence
申请人:——
公开号:US20040248933A1
公开(公告)日:2004-12-09
Provided herein are methods of using compounds of formula (IA-IF) that are aryl- and heteroaryl-substituted tetrahydroisoquinolines, for the treatment of chronic and neuropathic pain, the treatment and prevention of migraine headache, and the treatment of stress, urge and mixed urinary incontinence.
US7163949B1
申请人:——
公开号:US7163949B1
公开(公告)日:2007-01-16
[EN] 4-PHENYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE AND SEROTONIN<br/>[FR] TETRAHYDROISOQUINOLINES A SUBSTITUTION 4-PHENYLE ET UTILISATION DE CES DERNIERES POUR BLOQUER LE RECAPTAGE DE LA NOREPINEPHRINE, DE LA DOPAMINE ET DE LA SEROTONINE
申请人:DU PONT PHARM CO
公开号:WO2001032624A1
公开(公告)日:2001-05-10
Provided herein are compounds of formulae IA-IF. These compounds are tetrahydroisoquinolines of structure (A) wherein R1-R8 for compounds of each of the formulae IA, IB, IC, ID, IE and IF are as described herein. Said compounds are particularly useful in the treatment of various neurological and psychiatric disorders, e.g., ADHD.